These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25612283)

  • 21. Pityriasis rosea in a patient with Behçet's disease treated with interferon alpha 2A.
    Durusoy C; Alpsoy E; Yilmaz E
    J Dermatol; 1999 Apr; 26(4):225-8. PubMed ID: 10343467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.
    Atienza-Mateo B; Martín-Varillas JL; Graña J; Espinosa G; Moriano C; Pérez-Sandoval T; García-Armario MD; Castellví I; Román-Ivorra JA; Olivé A; Ybáñez A; Martinez-Ferrer A; Narváez J; Romero-Yuste S; Ojeda S; Ros I; Loricera J; Calvo-Río V; Castañeda S; Gonzalez-Gay MA; Blanco R;
    Clin Exp Rheumatol; 2020; 38 Suppl 127(5):69-75. PubMed ID: 33331268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent vulval ulceration: could it be Behcet's disease?
    Patel S; Prime K
    Int J STD AIDS; 2012 Sep; 23(9):683-4. PubMed ID: 23033529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha treatment of Behçet's disease.
    O'Duffy JD; Calamia K; Cohen S; Goronzy JJ; Herman D; Jorizzo J; Weyand C; Matteson E
    J Rheumatol; 1998 Oct; 25(10):1938-44. PubMed ID: 9779847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adamantiades-Behcet's disease].
    Krause L
    Ophthalmologe; 2005 Apr; 102(4):329-34. PubMed ID: 15668761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended venous thrombosis in Adamantiades-Behçet's disease.
    Zouboulis CC
    Eur J Dermatol; 2004; 14(4):268-71. PubMed ID: 15319164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe.
    Zouboulis CC; Kötter I; Djawari D; Kirch W; Kohl PK; Ochsendorf FR; Keitel W; Stadler R; Wollina U; Proksch E; Söhnchen R; Weber H; Gollnick HP; Hölzle E; Fritz K; Licht T; Orfanos CE
    Yonsei Med J; 1997 Dec; 38(6):411-22. PubMed ID: 9509911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal Behçet's disease without maternal history.
    Chang YS; Yang YH; Chiang BL
    Clin Rheumatol; 2011 Dec; 30(12):1641-5. PubMed ID: 21870036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients].
    Stübiger N; Kötter I; Deuter C; Zierhut M
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):768-73. PubMed ID: 11805868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G; Erdem U; Durukan AH; Erdurman C; Bayer A; Köksal S; Karagul S; Bayraktar MZ
    Ophthalmology; 2010 Jul; 117(7):1430-5. PubMed ID: 20417563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behçet's disease - part of the differential diagnosis of ulcerative lesions.
    Warren S; Alden K; Lomax N
    Int J STD AIDS; 2014 Dec; 25(14):1044-6. PubMed ID: 24676131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis.
    Onal S; Kazokoglu H; Koç A; Akman M; Bavbek T; Direskeneli H; Yavuz S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S113-4. PubMed ID: 19796551
    [No Abstract]   [Full Text] [Related]  

  • 34. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.
    Zhang L; Tian Y; Ye JF; Lin CH; Guan JL
    Orphanet J Rare Dis; 2019 Nov; 14(1):274. PubMed ID: 31779646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard and novel therapeutic approaches to Behçet's disease.
    Gul A
    Drugs; 2007; 67(14):2013-22. PubMed ID: 17883285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of interferon alpha 2A treatment in Behçet's disease.
    Boyvat A; Sişman-Solak C; Gürler A
    Dermatology; 2000; 201(1):40-3. PubMed ID: 10971058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.
    Yang P; Huang G; Du L; Ye Z; Hu K; Wang C; Qi J; Liang L; Wu L; Cao Q; Kijlstra A
    Ocul Immunol Inflamm; 2019; 27(1):7-14. PubMed ID: 29040035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excessive bleeding from genital ulcers of Behçet's disease.
    Bostankolu A; Aksungur VL; Aksungur EH; Ozpoyraz M; Yücel A; Memisoglu HR
    Cutis; 1997 Sep; 60(3):159-61. PubMed ID: 9314623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.